Brief: Lisata Therapeutics Announces Full Enrollment Of Pancreatic Cancer Cohort Of Cendifox Trial
13/06/2024 13:50
June 13 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS ANNOUNCES FULL ENROLLMENT OF
PANCREATIC
CANCER COHORT OF CENDIFOX TRIAL
Source text for Eikon: ID:nGNX8hRJfN
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal